“Combination of Calcipotriene Foam, 0.005% and Tazarotene Foam, 0.1% in the Treatment of Plaque Psoriasis of the Scalp and Body: A Case Report”, J of Skin, vol. 2, no. S1, p. S5, Feb. 2018, doi: 10.25251/skin.2.supp.5.